Innovent Biologics Inc
HKEX:1801
Innovent Biologics Inc
Pre-Tax Income
Innovent Biologics Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Innovent Biologics Inc
HKEX:1801
|
Pre-Tax Income
-¥1.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Pre-Tax Income
-¥6.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Pre-Tax Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Pre-Tax Income
¥2.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Pre-Tax Income
¥8.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
35%
|
CAGR 10-Years
50%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Pre-Tax Income
¥1.5B
|
CAGR 3-Years
62%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
See Also
What is Innovent Biologics Inc's Pre-Tax Income?
Pre-Tax Income
-1.1B
CNY
Based on the financial report for Dec 31, 2023, Innovent Biologics Inc's Pre-Tax Income amounts to -1.1B CNY.
What is Innovent Biologics Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
28%
Over the last year, the Pre-Tax Income growth was 47%. The average annual Pre-Tax Income growth rates for Innovent Biologics Inc have been -10% over the past three years , 28% over the past five years .